Rischka L, Murgaš M, Pichler V, Vraka C, Rausch I, Winkler D et al. Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[¹¹C]Me-NB1. EJNMMI Research. 2022;12(1):53. doi: 10.1186/s13550-022-00925-8

Klug S, Godbersen GM, Rischka L, Wadsak W, Pichler V, Klöbl M et al. Learning induces coordinated neuronal plasticity of metabolic demands and functional brain networks. Communications Biology. 2022;5:428. doi: 10.1101/2021.11.12.468351, 10.1038/s42003-022-03362-4

Godbersen G, Klug S, Wadsak W, Pichler V, Raitanen J, Rieckmann A et al. Task-positive networks differentially shape glucose metabolism of the posteromedial default mode network as revealed by [18F]FDG-PET/MR imaging. Neuroscience Applied. 2022;1(Suppl.2):100684. doi: 10.1016/j.nsa.2022.100684

Ozenil M, Skos L, Roller A, Gajic N, Holzer W, Spreitzer H et al. Unexpected scaffold rearrangement product of pirenzepine found in commercial samples. Scientific Reports. 2021 Dec 3;11(1):23397. doi: 10.1038/s41598-021-02732-y

Calabretta R, Staber PB, Kornauth C, Lu X, Binder P, Pichler V et al. Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age. Biology. 2021 Nov 19;10(11):1206. doi: 10.3390/biology10111206

Hahn A, Reed MB, Pichler V, Michenthaler P, Rischka L, Godbersen GM et al. Functional dynamics of dopamine synthesis during monetary reward and punishment processing. Journal of Cerebral Blood Flow and Metabolism. 2021 Nov;41(11):2973-2985. Epub 2021 May 30. doi: 10.1177/0271678X211019827

Kranz GS, Spies M, Vraka C, Kaufmann U, Klebermass EM, Handschuh PA et al. High-dose testosterone treatment reduces monoamine oxidase A levels in the human brain: A preliminary report. Psychoneuroendocrinology. 2021 Nov;133:105381. doi: 10.1016/j.psyneuen.2021.105381

Rischka L, Godbersen GM, Pichler V, Michenthaler P, Klug S, Klöbl M et al. Reliability of task-specific neuronal activation assessed with functional PET, ASL and BOLD imaging. Journal of Cerebral Blood Flow and Metabolism. 2021 Nov;41(11):2986-2999. Epub 2021 Jun 2. doi: 10.1177/0271678X211020589

Luurtsema G, Pichler V, Bongarzone S, Seimbille Y, Elsinga P, Gee A et al. EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality. EJNMMI Radiopharmacy and Chemistry. 2021 Oct 9;6(1):34. doi: 10.1186/s41181-021-00149-6

Klebermass EM, Mahmudi M, Geist BK, Pichler V, Vraka C, Balber T et al. If It Works, Don’t Touch It? A Cell-Based Approach to Studying 2-[18F]FDG Metabolism. Pharmaceuticals. 2021 Sept;14(9):910. doi: 10.3390/ph14090910

Ozenil M, Aronow J, Millard M, Langer T, Wadsak W, Hacker M et al. Update on PET Tracer Development for Muscarinic Acetylcholine Receptors. Pharmaceuticals. 2021 Jun 2;14(6):530. doi: 10.3390/ph14060530

Zisser L, Kulterer OC, Itariu B, Fueger B, Weber M, Mazal P et al. Diagnostic Role of PET/CT Tracers in the Detection and Localization of Tumours Responsible for Ectopic Cushing's Syndrome. Anticancer Research. 2021 May 1;41(5):2477-2484. doi: 10.21873/anticanres.15024

Rasul S, Hartenbach M, Wollenweber T, Kretschmer-Chott E, Grubmüller B, Kramer G et al. Prediction of response and survival after standardized treatment with 7400 MBq ¹⁷⁷Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2021 May;48(5):1650–1657. Epub 2020. doi: 10.1007/s00259-020-05082-5

Bauer M, Barna S, Blaickner M, Prosenz K, Bamminger K, Pichler V et al. Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [¹¹C]Metoclopramide. Molecular Imaging and Biology. 2021 Apr;23:180-185. doi: 10.1007/s11307-021-01582-4

Bauer M, Bamminger K, Pichler V, Weber M, Binder S, Maier-Salamon A et al. Impaired clearance from the brain increases the brain exposure to metoclopramide in elderly subjects. Clinical Pharmacology and Therapeutics. 2021 Mar;109(3):754-761. Epub 2020 Sept 23. doi: 10.1002/cpt.2052

Mayerhoefer ME, Raderer M, Lamm W, Pichler V, Pfaff S, Weber M et al. CXCR4 PET imaging of mantle cell lymphoma using [⁶⁸Ga]Pentixafor: Comparison with [¹⁸F]FDG-PET. Theranostics. 2021;11(2):567-578. doi: 10.7150/thno.48620

Sauerzopf U, Weidenauer A, Dajic I, Bauer M, Bartova L, Meyer B et al. Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia. NeuroImage: Clinical. 2021;32:102813. doi: 10.1016/j.nicl.2021.102813

Calabretta R, Hoeller C, Pichler V, Mitterhauser M, Karanikas G, Haug A et al. Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries. Circulation. 2020 Dec 15;142(24):2396–2398. doi: 10.1161/CIRCULATIONAHA.120.048708

Ozenil M, Aronow J, Piljak D, Vraka C, Holzer W, Spreitzer H et al. Synthesis, Biological, and Computational Evaluation of Antagonistic, Chiral Hydrobenzoin Esters of Arecaidine Targeting mAChR M1. Pharmaceuticals. 2020 Nov 30;13(12):1-12. 437. doi: 10.3390/ph13120437

Ozenil M, Pacher K, Balber T, Vraka C, Roller A, Holzer W et al. Enhanced arecoline derivatives as muscarinic acetylcholine receptor M1 ligands for potential application as PET radiotracers. European Journal of Medicinal Chemistry. 2020 Oct 15;204:112623. doi: 10.1016/j.ejmech.2020.112623